Predictive genetic testing is majorly implemented on next-generation sequencing (NGS) platforms and is used to predict future risks by providing information on an individual’s chromosomes and genetic mutations. It is widely used in clinical practices and translational research for predicting the risk of diseases such as neurodegenerative diseases and cancer. Common disorders include Huntington's disease, cystic fibrosis, phenylketonuria, Down's syndrome, breast cancer, and sickle cell anemia.
Predictive Genetic Testing Market: Key Players
The research study includes profiles of leading companies operating in the global predictive genetic testing market. Key players profiled in the report include: 23andMe, Inc., Abbott, Ambry Genetics, BGI, Biocartis Group NV, Bio-Helix Co. Ltd., bioMerieux SA, Blueprint Genetics, Cepheid, Counsyl, Inc., deCODE Genetics, GeneDx, Genomic Health, Inc., Genomictree, Inc., HTG Molecular Diagnostics, Inc., Illumina, Inc., IntegraGen, Invitae Corporation, LabCorp, and Others.
In July 2018, 23andMe Inc. entered into collaboration with GlaxoSmithKline plc. in order to discover novel targets for elucidation of disease progression pathways and develop therapies for disease eradication.
Drivers for the Global Predictive Genetic Testing Market:
Growing automation in sequencing methodologies, along with introduction of efficient and rapid genomic sequencing procedures, is anticipated to boost advances in predictive genetic tests based on the NGS principle. Moreover, higher penetration of outsourcing has resulted in the emergence of several companies that are engaged in providing ‘sequencing-as-a-service’ or range of sample-to-insight services.
Opportunities for the Global Predictive Genetic Testing Market:
Technological advancements in genetic testing will propel the global market demand in the forecast timeframe. Further, increased R&D efforts enable fast and cost-effective sequencing of DNA.
Region Wise, Global Predictive Genetic Testing Market Analysis:
North America dominated the market by revenue owing to presence of several players based in U.S. Additionally, high awareness level, prevalence of chronic diseases, and high adoption of new technologies makes North America as maximum shareholder of the market in terms of regional analysis. However, Asia Pacific is anticipated to grow at a significant rate due to the growing population, rise in disposable income, increasing demand for genetic testing, prevalence of unhealthy lifestyles, and mounting government intervention in the development of health care infrastructure.
Global Predictive Genetic Testing Market: Product analysis
- Predictive Testing
- Consumer Genomics
- Wellness Genomics
Global Predictive Genetic Testing Market: Application analysis
- Breast and Ovarian Cancer
- Cardiovascular screening
- Diabetic Screening and Monitoring
- Colon Cancer
- Other
Global Predictive Genetic Testing Market: Region analysis
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- ASEAN
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Colombia
- Rest of L.A.
- Middle East and Africa
- Turkey
- GCC
- UAE
- South Africa
- Rest of Middle East
Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialist with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever new fun research methods developed by our team.
Contact Us:
Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974
Email: [email protected]
Web: proficientmarket.com
